Literature DB >> 33630060

Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis.

Majd Bairkdar1, Marios Rossides1, Helga Westerlind1, Roger Hesselstrand2, Elizabeth V Arkema1, Marie Holmqvist1,3.   

Abstract

OBJECTIVES: We aimed to conduct a systematic review and meta-analysis on the incidence and prevalence of SSc covering the entire literature.
METHODS: This study followed the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement of 2009. We conducted a systematic search in MEDLINE, Web of Science and Embase to identify articles reporting incidence and/or prevalence of SSc. Two authors conducted the search, reviewed articles for inclusion and extracted relevant data. We used random-effects models to estimate the pooled prevalence and incidence of SSc and performed subgroup analyses by sex, case definition and region to investigate heterogeneity. We explored the association between calendar period and reported estimates using meta-regression.
RESULTS: Among 6983 unique records identified, we included 61 studies of prevalence and 39 studies of incidence in the systematic review. The overall pooled prevalence of SSc was 17.6 (95% CI 15.1, 20.5) per 100 000 and the overall pooled incidence rate of SSc was 1.4 (95% CI 1.1, 1.9) per 100 000 person-years. We observed significant regional variations in reported estimates; studies conducted in North America reported considerably higher estimates than other regions. The pooled incidence and prevalence in women were five times higher than in men. More recent studies reported higher estimates than older ones.
CONCLUSION: In this comprehensive review of the incidence and prevalence of SSc across the world, there was large heterogeneity among estimates, which should be taken into consideration when interpreting the results.
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology.

Entities:  

Keywords:  incidence; meta-analysis; prevalence; systematic review; systemic sclerosis

Year:  2021        PMID: 33630060     DOI: 10.1093/rheumatology/keab190

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  7 in total

Review 1.  Systemic sclerosis in Asians: Are there racial differences?

Authors:  Sue-Ann Ng; Andrea Hsiu Ling Low
Journal:  J Scleroderma Relat Disord       Date:  2022-02-03

Review 2.  Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases.

Authors:  Hideyuki Ujiie; David Rosmarin; Michael P Schön; Sonja Ständer; Katharina Boch; Martin Metz; Marcus Maurer; Diamant Thaci; Enno Schmidt; Connor Cole; Kyle T Amber; Dario Didona; Michael Hertl; Andreas Recke; Hanna Graßhoff; Alexander Hackel; Anja Schumann; Gabriela Riemekasten; Katja Bieber; Gant Sprow; Joshua Dan; Detlef Zillikens; Tanya Sezin; Angela M Christiano; Kerstin Wolk; Robert Sabat; Khalaf Kridin; Victoria P Werth; Ralf J Ludwig
Journal:  Front Med (Lausanne)       Date:  2022-06-09

3.  Atherosclerosis in Vietnamese patients with systemic sclerosis and its relationship to disease and traditional risk factors.

Authors:  Thuy Nguyen Thi Phuong; Trang Dao Thi; Ingrid E Lundberg; Binh Nguyen Huy
Journal:  Rheumatol Adv Pract       Date:  2022-06-02

4.  IL-33/Regulatory T-Cell Axis Suppresses Skin Fibrosis.

Authors:  Se Yun Cheon; Jong Ho Park; Amir H Ameri; Richard T Lee; Rosalynn M Nazarian; Shadmehr Demehri
Journal:  J Invest Dermatol       Date:  2022-03-25       Impact factor: 7.590

5.  Th17 cell-derived miR-155-5p modulates interleukin-17 and suppressor of cytokines signaling 1 expression during the progression of systemic sclerosis.

Authors:  Li Han; Qin Lv; Kelei Guo; Linyun Li; Hong Zhang; Hua Bian
Journal:  J Clin Lab Anal       Date:  2022-05-11       Impact factor: 3.124

Review 6.  Systemic Scleroderma-Definition, Clinical Picture and Laboratory Diagnostics.

Authors:  Anna Kowalska-Kępczyńska
Journal:  J Clin Med       Date:  2022-04-20       Impact factor: 4.964

7.  Scleroderma and interstitial lung disease - A case report.

Authors:  Fahad Gul; Amna Siddiqui; Prakhyath Srikaram; Nabeela Fatima
Journal:  Ann Med Surg (Lond)       Date:  2022-07-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.